Loading patent…
AssigneeIDEXX Laboratories, Inc.
InventorsPhilip Andersen, Melissa Jane Beall, Jesse Buch, Ku-chuan Hsiao, Stacey Pazar Huth, Eugene Regis Krah, III, Barbara O'Brien, Marilyn Strong-Townsend
Estimating the term…
Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.
A monoclonal antibody produced by a cell line having ATCC patent deposit number PTA-8506 or PTA-8507.
A kit for detecting the presence or amount of feline pancreatic lipase polypeptide (fPLP) in a sample, comprising:
A cell line having ATCC patent deposit number PTA-8506 or PTA-8507.
Dependencies are inferred from the claim text.